aTyr Pharma (LIFE) Trims Q3 Loss

aTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.48), versus ($8.02) reported last year.

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Ethos Signs Erin Andrews as Its Next Sports Partner in Growing Campaign to Make Life Insurance Accessible for Every Family
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• RCM Technologies (RCMT) Tops Q2 EPS by 17c